Process Industries · Chemicals: Agricultural · NSE: 3BBLACKBIO · data 2026-10-09
3B BlackBio Dx Ltd
Health check: Strong (7.2/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹1,586.4
Market cap
₹1,315 cr
P/E
24.5
P/B
—
ROE
20.2%
ROCE
17.1%
Debt / equity
0.01
Dividend yield
0.33%
1-year return
19.3%
52-week high
₹1,740
52-week low
₹1,085
Operating margin
30.9%
Growth
| Revenue (last 12 months) | ₹153 cr |
| Net profit (last 12 months) | ₹56 cr |
| Sales growth, 3 years (yearly) | 31.9% |
| Profit growth, 3 years (yearly) | 32.2% |
Similar companies
Astec Lifesciences Limited (ASTEC) · India Pesticides Ltd. (IPL) · Southern Petrochemical Industries Corporation Limited (SPIC) · Punjab Chemicals & Crop Protection Ltd. (PUNJABCHEM) · Excel Industries Limited (EXCELINDUS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open 3BBLACKBIO in NSE Scanner →